Clusterin may be a therapeutic target for preventing brain injury after hypoxia-ischaemia

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1287, 2001-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Altered Homeostatic Functions in Reactive Astrocytes and Their Potential as a Therapeutic Target After Brain Ischemic Injury

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 5056-5074

Bentham Science Publishers

Access to resources Recommend Favorite

Activin A a therapeutic target in brain injury?

Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

GLT-1 Upregulation as a Potential Therapeutic Target for Ischemic Brain Injury

Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. : 5045-5055

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Role of Taurine in Ischaemia-Reperfusion Injury

Current Pharmaceutical Design, Vol. 10, Iss. 19, 2004-07 ,pp. : 2401-2410

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Silencing using siRNA for Preventing Liver Ischaemia-Reperfusion Injury

Current Pharmaceutical Design, Vol. 24, Iss. 23, 2018-06 ,pp. : 2692-2700

Bentham Science Publishers

Access to resources Recommend Favorite